Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xu Chao

Showing results (151-160 of 281) with videos related to

Pageof 29
Sort By:
Oncotarget|May 24, 2016
Plasma dynamic monitoring of soluble c-Met level for EGFR-TKI treatment in advanced non-small cell lung cancerHong-Fei Gao, Jin-Ji Yang, Zhi-Hong Chen, et al.
JTO Clinical and Research Reports|December 17, 2021
Response to Icotinib Plus Chemotherapy in Pulmonary Atypical Carcinoid Harboring the <i>EGFR</i> L858R Mutation: A Brief ReportYu-Qing Chen, Yu-Fa Li, Chan-Yuan Zhang, et al.
Cancer Letters|April 15, 2008
Better survival with EGFR exon 19 than exon 21 mutations in gefitinib-treated non-small cell lung cancer patients is due to differential inhibition of downstream signalsJian-quan Zhu, Wen-zhao Zhong, Guo-chun Zhang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 18, 2012
A clinical model to estimate the pretest probability of lung cancer, based on 1198 pedigrees in ChinaHuan Lin, Wen-Zhao Zhong, Xue-Ning Yang, et al.
European Journal of Cancer (Oxford, England : 1990)|May 28, 2011
CYP1A1*2A polymorphism as a predictor of clinical outcome in advanced lung cancer patients treated with EGFR-TKI and its combined effects with EGFR intron 1 (CA)n polymorphismQiang Nie, Xue-Ning Yang, She-Juan An, et al.
Cancer Treatment and Research Communications|January 1, 2021
Gene co-expression modules integrated with immunoscore predicts survival of non-small cell lung cancerXue-Tao Li, Jia-Tao Zhang, Hong-Hong Yan, et al.
Biochimica Et Biophysica Acta|January 19, 2011
Ergosta-4,6,8(14),22-tetraen-3-one induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cellsYing-Yong Zhao, Xuefeng Shen, Xu Chao, et al.
Lung Cancer (Amsterdam, Netherlands)|January 22, 2016
Predictive and prognostic value of de novo MET expression in patients with advanced non-small-cell lung cancerAnna Li, Fei-Yu Niu, Jie-Fei Han, et al.
Combinatorial Chemistry & High Throughput Screening|June 18, 2026
Mechanistic Study on the Treatment of Acute Lung Injury with Qingwen Baidu Decoction based on NLRP3 Inflammasome Signaling PathwayJinhui Feng, Xiangzheng Mao, Wenting Wang, et al.
Frontiers in Neurology|June 2, 2022
The Recipient Vessel Hemodynamic Features Affect the Occurrence of Cerebral Edema in Moyamoya Disease After Surgical Revascularization: A Single-Center Retrospective StudyLiang Xu, Yin Li, Yun Tong, et al.
Pageof 29

Showing results (151-160 of 281) with videos related to

Sort By:
Pageof 29
Oncotarget|May 24, 2016
Plasma dynamic monitoring of soluble c-Met level for EGFR-TKI treatment in advanced non-small cell lung cancerHong-Fei Gao, Jin-Ji Yang, Zhi-Hong Chen, et al.
JTO Clinical and Research Reports|December 17, 2021
Response to Icotinib Plus Chemotherapy in Pulmonary Atypical Carcinoid Harboring the <i>EGFR</i> L858R Mutation: A Brief ReportYu-Qing Chen, Yu-Fa Li, Chan-Yuan Zhang, et al.
Cancer Letters|April 15, 2008
Better survival with EGFR exon 19 than exon 21 mutations in gefitinib-treated non-small cell lung cancer patients is due to differential inhibition of downstream signalsJian-quan Zhu, Wen-zhao Zhong, Guo-chun Zhang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 18, 2012
A clinical model to estimate the pretest probability of lung cancer, based on 1198 pedigrees in ChinaHuan Lin, Wen-Zhao Zhong, Xue-Ning Yang, et al.
European Journal of Cancer (Oxford, England : 1990)|May 28, 2011
CYP1A1*2A polymorphism as a predictor of clinical outcome in advanced lung cancer patients treated with EGFR-TKI and its combined effects with EGFR intron 1 (CA)n polymorphismQiang Nie, Xue-Ning Yang, She-Juan An, et al.
Cancer Treatment and Research Communications|January 1, 2021
Gene co-expression modules integrated with immunoscore predicts survival of non-small cell lung cancerXue-Tao Li, Jia-Tao Zhang, Hong-Hong Yan, et al.
Biochimica Et Biophysica Acta|January 19, 2011
Ergosta-4,6,8(14),22-tetraen-3-one induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cellsYing-Yong Zhao, Xuefeng Shen, Xu Chao, et al.
Lung Cancer (Amsterdam, Netherlands)|January 22, 2016
Predictive and prognostic value of de novo MET expression in patients with advanced non-small-cell lung cancerAnna Li, Fei-Yu Niu, Jie-Fei Han, et al.
Combinatorial Chemistry & High Throughput Screening|June 18, 2026
Mechanistic Study on the Treatment of Acute Lung Injury with Qingwen Baidu Decoction based on NLRP3 Inflammasome Signaling PathwayJinhui Feng, Xiangzheng Mao, Wenting Wang, et al.
Frontiers in Neurology|June 2, 2022
The Recipient Vessel Hemodynamic Features Affect the Occurrence of Cerebral Edema in Moyamoya Disease After Surgical Revascularization: A Single-Center Retrospective StudyLiang Xu, Yin Li, Yun Tong, et al.
Pageof 29